| pubmed-article:16424679 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0079744 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0011777 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0205177 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0069717 | lld:lifeskim |
| pubmed-article:16424679 | lifeskim:mentions | umls-concept:C0733521 | lld:lifeskim |
| pubmed-article:16424679 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16424679 | pubmed:dateCreated | 2006-2-7 | lld:pubmed |
| pubmed-article:16424679 | pubmed:abstractText | Patients with relapsed diffuse large B-cell lymphoma (DLBCL) who are either not suitable for stem cell transplantation or suffer from relapsed disease after standard second-line chemotherapy face a dismal prognosis. Most of them have a reduced performance status and do not tolerate intensive chemotherapy. | lld:pubmed |
| pubmed-article:16424679 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16424679 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16424679 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16424679 | pubmed:issn | 0030-2414 | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:RadererMarkus... | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:JaegerUlrichU | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:SkrabsCathrin... | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:DrachJohannes... | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:ZielinskiChri... | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:HejnaMichaelM | lld:pubmed |
| pubmed-article:16424679 | pubmed:author | pubmed-author:WoehrerStefan... | lld:pubmed |
| pubmed-article:16424679 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16424679 | pubmed:volume | 69 | lld:pubmed |
| pubmed-article:16424679 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16424679 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16424679 | pubmed:pagination | 499-502 | lld:pubmed |
| pubmed-article:16424679 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:meshHeading | pubmed-meshheading:16424679... | lld:pubmed |
| pubmed-article:16424679 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16424679 | pubmed:articleTitle | Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphoma. | lld:pubmed |
| pubmed-article:16424679 | pubmed:affiliation | Division of Bone Marrow Transplantation, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria. | lld:pubmed |
| pubmed-article:16424679 | pubmed:publicationType | Journal Article | lld:pubmed |
